0001209191-23-056514.txt : 20231122 0001209191-23-056514.hdr.sgml : 20231122 20231122171801 ACCESSION NUMBER: 0001209191-23-056514 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231121 FILED AS OF DATE: 20231122 DATE AS OF CHANGE: 20231122 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Roemer Alan S. CENTRAL INDEX KEY: 0001643070 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40045 FILM NUMBER: 231434447 MAIL ADDRESS: STREET 1: C/O AXOVANT SCIENCES, INC. STREET 2: 1441 BROADWAY, 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NexImmune, Inc. CENTRAL INDEX KEY: 0001538210 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9119 GAITHER ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 301-825-9810 MAIL ADDRESS: STREET 1: 9119 GAITHER ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-11-21 0 0001538210 NexImmune, Inc. NEXI 0001643070 Roemer Alan S. C/O NEXIMMUNE, INC. 9119 GAITHER ROAD GAITHERSBURG MD 20877 1 0 0 0 0 Common Stock 2023-11-21 4 S 0 3833 2.1621 D 3992 D Common Stock 2023-11-22 4 S 0 3992 1.9434 D 0 D The price reflects the average selling price of the common stock sold. These shares were sold in multiple transactions at prices ranging from $2.05 to $2.39 per common stock. The Reporting Person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of common stock sold at each price. The price reflects the average selling price of the common stock sold. These shares were sold in multiple transactions at prices ranging from $1.91 to $2.05 per common stock. The Reporting Person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of common stock sold at each price. /s/John Rudy, attorney-in-fact 2023-11-22